Substance
SITAGLIPTIN PHOSPHATE
Global reference: every product and company linked to this substance.
- cas: 654671-77-9
- ncit: C73811
- pubchem_cid: 11591741
- rxnorm: 621590
- unii: TS63EW8X6F
GLACTIV · JANUMET COMPONENT SITAGLIPTIN PHOSPHATE · JANUVIA · MK-0431 · MK0431 · ONO-5435 · SITAGLIPTIN PHOSPHATE [JAN] · SITAGLIPTIN PHOSPHATE [USAN] · SITAGLIPTIN PHOSPHATE HYDRATE [JAN] · Sitagliptin phosphate monohydrate [WHO-DD] · STEGLUJAN COMPONENT SITAGLIPTIN PHOSPHATE · STELUJAN COMPONENT SITAGLIPTIN PHOSPHATE
Revenue by product (2)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| MERCK & COMPANY INC. COMMON STOCK (NEW) | JANUVIA | Q2 2026 | $258.0M |
| MERCK & COMPANY INC. COMMON STOCK (NEW) | JANUMET | Q2 2026 | $171.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (7)
- JANUMET · MERCK & COMPANY INC. COMMON STOCK (NEW)
- JANUMET XR · MERCK & COMPANY INC. COMMON STOCK (NEW)
- JANUVIA · MERCK & COMPANY INC. COMMON STOCK (NEW)
- JUVISYNC · MERCK & COMPANY INC. COMMON STOCK (NEW)
- SITAGLIPTIN PHOSPHATE · DR. REDDY'S LABORATORIES LTD COMMON STOCK
- SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
- STEGLUJAN · MERCK & COMPANY INC. COMMON STOCK (NEW)